ENGN Insider Trading Activity and SEC Form 4 Filings
ENGN insider trading summary
Over the past 12 months, insiders at enGene Therapeutics Inc. (ENGN) reported 1 open-market purchase worth $10K by 1 insider and no sales on SEC Form 4. Net insider buying was $10K.
Latest ENGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 22, 2026 | William Grossman | Interim Chief Medical Officer | Buy | $10K (5,102 @ $1.97) |
| Oct 30, 2024 | Forbion Growth Management B.V. | Insider | Buy | $5.0M (561,797 @ $8.90) |
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | Insider | Buy | $5.0M (561,797 @ $8.90) |
| Oct 8, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | Insider | Buy | $5K (800 @ $6.60) |
| Oct 8, 2024 | Forbion Growth Management B.V. | Insider | Buy | $5K (800 @ $6.60) |
| Oct 7, 2024 | Forbion Growth Management B.V. | Insider | Buy | $78K (11,844 @ $6.55) |
| Oct 7, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | Insider | Buy | $78K (11,844 @ $6.55) |
| Oct 4, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | Insider | Buy | $39K (5,997 @ $6.54) |
| Oct 4, 2024 | Forbion Growth Management B.V. | Insider | Buy | $39K (5,997 @ $6.54) |
| Oct 3, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | Insider | Buy | $37K (5,769 @ $6.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.